Niowave breaks ground on $75M radioisotope plant in Michigan; CordenPharma to acquire AmbioPharm
read at Endpoints ↗DealNeutral
Niowave announced it has started construction of a new radioisotope production facility in Lansing, Michigan, with an investment of about $75 million.
The plant will produce radioisotopes used in medical imaging and therapy, aiming to boost domestic supply.
In separate news, CordenPharma disclosed plans to acquire AmbioPharm, reflecting ongoing consolidation in the contract manufacturing sector.
The announcements were released alongside Agilent's earnings report, though the report details were not included in the excerpt.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Niowave’s $75M radioisotope facility; CordenPharma to buy AmbioPharm”
read at Endpoints ↗75 words · retrieved Jun 3
comments(0)
5-min edit window · permanent after that